Florida Trim Clinic · Education & Evidence
Each link below identifies the topic it supports. Sources describe their own research or educational guidance, not Florida Trim Clinic’s services or patient outcomes. Their inclusion does not imply endorsement, affiliation or sponsorship.
PubMed / Clinical Interventions in Aging
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?Supports: An editorial discussing a proposed rationale for sermorelin; not randomized evidence of improved muscle, sleep, recovery, fat loss or safety in healthy adults.
PubMed / Annals of Internal Medicine
Systematic review: the safety and efficacy of growth hormone in the healthy elderlySupports: Limited benefits and increased adverse events with growth hormone in healthy older adults; this is not a sermorelin treatment trial.
U.S. Food and Drug Administration
Compounding and the FDA: Questions and AnswersSupports: What compounding means, when it may address a patient's medical need, and how it differs from FDA drug approval.
Walker RF. Clinical Interventions in Aging. 2006.
Research published in Clinical Interventions in Aging reported a proposed rationale for sermorelin in an editorial. This is not a randomized clinical trial and does not establish the benefits claimed for healthy adults.
Liu H, Bravata DM, Olkin I, et al. Annals of Internal Medicine. 2007.
Research published in Annals of Internal Medicine reported small body-composition changes and increased adverse events with growth hormone in healthy older adults. The review is not evidence that sermorelin is effective or safer, and should not be extrapolated to establish anti-aging benefits.
Florida Trim Clinic’s educational information is general and is not individualized medical advice. Prescription treatment requires evaluation by a licensed provider. Eligibility, medication selection and dosing depend on individual circumstances.
Compounded drugs are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before marketing.
Compounded products are not FDA-approved versions of brand-name drugs, and clinical trials of approved products do not establish equivalent safety or effectiveness for compounded products. FDA registration of a facility is not FDA approval of its compounded medicines. FDA advises compounded drugs should only be used for patients whose medical needs cannot be met by an FDA-approved drug. Availability and prescribing are subject to applicable law and individual provider evaluation.
For compounded GLP-1 medicines, FDA has reported dosing errors and product-quality concerns. Semaglutide sodium and semaglutide acetate are different active ingredients from the one in approved medicines. Follow the licensed provider’s and dispensing pharmacy’s instructions; discuss dosing, storage and any adverse effects with them. Read FDA’s current compounded GLP-1 safety information.
Our Origin
South Florida Trim Clinic in Naples was the first location and the origin of the Trim Clinic Network. It started with licensed medical providers, personalized care, and no membership fees, ever.
Prescription care requires an evaluation by a licensed provider, and treatment is offered only where it is clinically appropriate and you are eligible.